- Home
- LABT vs MTR Comparison
LABT vs MTR Comparison
Compare LABT & MTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LABT | MTR |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3M | 5.8M |
| IPO Year | 2026 | N/A |
Fundamental Metrics
Financial Performance| Metric | LABT | MTR |
|---|---|---|
| Price | $2.29 | $2.74 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 191.1K | 6.1K |
| Earning Date | N/A | 03-31-2026 |
| Dividend Yield | N/A | ★ 4.82% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $22.60 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.66 | $2.67 |
| 52 Week High | $6.85 | $5.83 |
Technical Indicators
Market Signals| Indicator | LABT | MTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.95 | 23.84 |
| Support Level | $2.07 | N/A |
| Resistance Level | $2.48 | $3.00 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 39.64 | 13.46 |
Price Performance
Historical ComparisonAbout LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock
Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.
About MTR Mesa Royalty Trust
Mesa Royalty Trust holds net overriding royalty interests in various oil and gas properties located in the: Hugoton field of Kansas, San Juan Basin field of New Mexico, and San Juan Basin Field of Colorado.